In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death.

cam.issuedOnline2022-06-29
dc.contributor.authorMohkam, Kayvan
dc.contributor.authorNasralla, David
dc.contributor.authorMergental, Hynek
dc.contributor.authorMuller, Xavier
dc.contributor.authorButler, Andrew
dc.contributor.authorJassem, Wayel
dc.contributor.authorImber, Charles
dc.contributor.authorMonbaliu, Diethard
dc.contributor.authorPerera, M Thamara PR
dc.contributor.authorLaing, Richard W
dc.contributor.authorGarcía-Valdecasas, Juan Carlos
dc.contributor.authorPaul, Andreas
dc.contributor.authorDondero, Federica
dc.contributor.authorCauchy, François
dc.contributor.authorSavier, Eric
dc.contributor.authorScatton, Olivier
dc.contributor.authorRobin, Fabien
dc.contributor.authorSulpice, Laurent
dc.contributor.authorBucur, Petru
dc.contributor.authorSalamé, Ephrem
dc.contributor.authorPittau, Gabriella
dc.contributor.authorAllard, Marc-Antoine
dc.contributor.authorPradat, Pierre
dc.contributor.authorRossignol, Guillaume
dc.contributor.authorMabrut, Jean-Yves
dc.contributor.authorPloeg, Rutger J
dc.contributor.authorFriend, Peter J
dc.contributor.authorMirza, Darius F
dc.contributor.authorLesurtel, Mickaël
dc.contributor.authorConsortium for Organ Preservation in Europe (COPE)
dc.contributor.orcidMohkam, Kayvan [0000-0002-9695-0902]
dc.contributor.orcidMergental, Hynek [0000-0001-5480-9380]
dc.contributor.orcidMuller, Xavier [0000-0002-8849-5495]
dc.contributor.orcidSavier, Eric [0000-0003-4131-2222]
dc.contributor.orcidRossignol, Guillaume [0000-0002-9896-4144]
dc.contributor.orcidMabrut, Jean-Yves [0000-0002-5701-3588]
dc.contributor.orcidLesurtel, Mickaël [0000-0003-2397-4599]
dc.date.accessioned2022-06-29T19:50:53Z
dc.date.available2022-06-29T19:50:53Z
dc.date.issued2022-11
dc.date.submitted2021-09-18
dc.date.updated2022-06-29T19:50:53Z
dc.description.abstractIn situ normothermic regional perfusion (NRP) and ex situ normothermic machine perfusion (NMP) aim to improve the outcomes of liver transplantation (LT) using controlled donation after circulatory death (cDCD). NRP and NMP have not yet been compared directly. In this international observational study, outcomes of LT performed between 2015 and 2019 for organs procured from cDCD donors subjected to NRP or NMP commenced at the donor center were compared using propensity score matching (PSM). Of the 224 cDCD donations in the NRP cohort that proceeded to asystole, 193 livers were procured, resulting in 157 transplants. In the NMP cohort, perfusion was commenced in all 40 cases and resulted in 34 transplants (use rates: 70% vs. 85% [p = 0.052], respectively). After PSM, 34 NMP liver recipients were matched with 68 NRP liver recipients. The two cohorts were similar for donor functional warm ischemia time (21 min after NRP vs. 20 min after NMP; p = 0.17), UK-Donation After Circulatory Death risk score (5 vs. 5 points; p = 0.38), and laboratory Model for End-Stage Liver Disease scores (12 vs. 12 points; p = 0.83). The incidence of nonanastomotic biliary strictures (1.5% vs. 2.9%; p > 0.99), early allograft dysfunction (20.6% vs. 8.8%; p = 0.13), and 30-day graft loss (4.4% vs. 8.8%; p = 0.40) were similar, although peak posttransplant aspartate aminotransferase levels were higher in the NRP cohort (872 vs. 344 IU/L; p < 0.001). NRP livers were more frequently allocated to recipients suffering from hepatocellular carcinoma (HCC; 60.3% vs. 20.6%; p < 0.001). HCC-censored 2-year graft and patient survival rates were 91.5% versus 88.2% (p = 0.52) and 97.9% versus 94.1% (p = 0.25) after NRP and NMP, respectively. Both perfusion techniques achieved similar outcomes and appeared to match benchmarks expected for donation after brain death livers. This study may inform the design of a definitive trial.
dc.identifier.doi10.17863/CAM.86029
dc.identifier.eissn1527-6473
dc.identifier.issn1527-6465
dc.identifier.otherlt26522
dc.identifier.otherlt-21-715.r2
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/338616
dc.languageen
dc.publisherOvid Technologies (Wolters Kluwer Health)
dc.publisher.urlhttp://dx.doi.org/10.1002/lt.26522
dc.subjectAspartate Aminotransferases
dc.subjectCarcinoma, Hepatocellular
dc.subjectEnd Stage Liver Disease
dc.subjectGraft Survival
dc.subjectHumans
dc.subjectLiver Neoplasms
dc.subjectLiver Transplantation
dc.subjectOrgan Preservation
dc.subjectPerfusion
dc.subjectSeverity of Illness Index
dc.titleIn situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death.
dc.typeArticle
dcterms.dateAccepted2022-03-19
prism.publicationNameLiver Transpl
pubs.funder-project-idEuropean Commission Seventh Framework Programme Grant (305934)
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc/4.0/
rioxxterms.versionAO
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1002/lt.26522
Files
Original bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
lt.26522.xml
Size:
17.9 KB
Format:
Extensible Markup Language
Description:
Bibliographic metadata
Licence
http://creativecommons.org/licenses/by-nc/4.0/
Loading...
Thumbnail Image
Name:
lt.26522.pdf
Size:
1.21 MB
Format:
Adobe Portable Document Format
Description:
Published version
Licence
http://creativecommons.org/licenses/by-nc/4.0/